PDCD1 and melanoma: Thus, l-fuc can suppress some melanomas as effectively as anti-PD1 therapy, whereas, in others, it can enhance efficacy, which is associated with increased intratumoral CD4+ T central and effector memory subpopulations and lymph node cDC2 and moDC populations, consistent with the effects of l-fuc observed in Fig. 2.